RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. Their mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis.

RevMAb Biosciences USA, Inc is located in heart of South San Francisco, the biotechnology hub of the Bay Area, and home to many of the largest and most successful biotechnology and pharmaceutical companies in the world.